After Pfizer and Serum Institute of India (SII), Hyderabad-based pharmaceutical company Bharat Biotech on Monday applied to the Central Drug Regulator to obtain approval for emergency use for its anti-Covid-19 vaccine. for emergency use of Covaxin). Official sources gave this information. The covaxine vaccine is being developed indigenously by Bharat Biotech in collaboration with the Indian Council of Medical Research.
Prime Minister Narendra Modi in his address on Monday after inaugurating the Agra Metro Rail Project through video conferencing said that the corona vaccine is awaited. Recently, meeting the scientists did not feel that it is too late now. Earlier, at an all-party meeting on December 4, he hoped that the Covid-19 vaccine could be ready in a few weeks. In the evening of the same day, the Indian branch of American pharmaceutical company Pfizer sought approval from the central drug regulator for emergency use of its vaccine. Earlier this company has received such approval in the UK and Bahrain.
The applications of Bharat Biotech, Serum Institute of India and Pfizer are likely to be considered by the Subject Expert Committee on Covid-19 at the Central Drugs Standard Control Organization on Wednesday .. Official sources said, ‘However None of these applications has been sent to the committee so far and no date has been set as to when the committee will meet to evaluate the applications.
